Losing sleep over cancer

Journal of Clinical Oncology

Volumn 26, Issue 15, 2008, Pages 2431-2432

  Spiegel, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; CYTOKINE; HYDROCORTISONE;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CIRCADIAN RHYTHM; COLORECTAL CANCER; COMORBIDITY; DEMOGRAPHY; DEPRESSION; EDITORIAL; ENDOMETRIUM CANCER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEOPLASM; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; REM SLEEP; SLEEP AROUSAL DISORDER; SLEEP WAKING CYCLE; SOCIAL STRESS; SOLID TUMOR; NOTE; SLEEP DISORDER;

CIRCADIAN RHYTHM; HUMANS; NEOPLASMS; SLEEP DISORDERS;

EID: 45149123643     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.2008     Document Type: Editorial

References (31)

1. Parker KP, Bliwise DL, Ribeiro M, et al: Sleep/wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol 26:2464-2472, 2008
2. Cohen-Zion M, Stepnowsky C, Marler et al: Changes in cognitive function associated with sleep disordered breathing in older people. J Am Geriatr Soc 49:1622-1627, 2001
3. Ancoli-Israel S, Liu L, Marler MR, et al: Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 14:201-209, 2006
4. Levin RD, Daehler MA, Grutsch JF, et al: Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 93:1202-1208, 2005
5. Liu L, Marler MR, Parker BA, et al: The relationship between fatigue and light exposure during chemotherapy. Support Care Cancer 13:1010-1017, 2005
6. Rich T, Innominato PF, Boerner J, et al: Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 11:1757-1764, 2005
7. Capuron L, Gumnick JF, Musselman DL, et al: Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26:643-652, 2002
8. Musselman DL, Lawson DH, Gumnick JF, et al: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961-966, 2001
9. Sapolsky RM, Donnelly TM: Vulnerability to stress-induced tumor growth increases with age in rats: Role of glucocorticoids. Endocrinology 117:662-666, 1985
10. Sapolsky RM, Krey LC, McEwen BS: The adrenocortical stress-response in the aged male rat: Impairment of recovery from stress. Exp Gerontol 18:55-64, 1983
11. Ben-Eliyahu S, Yirmiya R, Liebeskind JC, et al: Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system. Brain Behav Immun 5:193-205, 1991
12. Czeisler CA, Duffy JF, Shanahan TL, et al: Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 284:2177-2181, 1999
13. Fu L, Pelicano H, Liu J, et al: The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41-50, 2002
14. Fu L, Lee CC: The circadian clock: Pacemaker and tumour suppressor. Nat Rev Cancer 3:350-361, 2003
15. Gery S, Komatsu N, Baldjyan L, et al: The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22:375-382, 2006
16. Chen-Goodspeed M, Lee CC: Tumor suppression and circadian function. J Biol Rhythms 22:291-298, 2007
17. Touitou Y, Levi F, Bogdan A, et al: Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J Cancer Res Clin Oncol 121:181-188, 1995
18. van der Pompe G, Antoni MH, Heijnen CJ: Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 21:361-374, 1996
19. Sephton SE, Sapolsky RM, Kraemer HC, et al: Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92:994-1000, 2000
20. Spiegel D, Giese-Davis J, Taylor CB, et al: Stress sensitivity in metastatic breast cancer: Analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 31:1231-1244, 2006
21. Mormont MC, Waterhouse J, Bleuzen P, et al: Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6:3038-3045, 2000
22. Davis S, Mirick D, Stevens R: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557-1562, 2001
23. Schernhammer E, Laden F, Speizer F, et al: Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 93:1563-1568, 2001
24. Spiegel D, Sephton S: Re: Night shift work, light and night, and risk of breast cancer. J Natl Cancer Inst 94:530, 2002
25. Shafii M, Shafii SL: Melatonin in psychiatric and neoplastic disorders. Washington, DC, American Psychiatric Press Inc, 1998, pp xxiii, 314
26. Zhao X-Y, Malloy PJ, Krishnan AV, et al: Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor. Nat Med 6:703-706, 2000
27. Filipski E, King VM, Li X, et al: Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94:690-697, 2002
28. Lévi F: Circadian chronotherapy for human cancers. Lancet Oncol 2:307-315, 2001
29. Giacchetti S, Bjarnason G, Garufi C, et al: Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol 24:3562-3569, 2006
30. Gholam D, Giacchetti S, Brezault-Bonnet C, et al: Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer. Oncologist 11:1072-1080, 2006
31. Lévi F: From circadian rhythms to cancer chronotherapeutics. Chronobiol Int 19:1-19, 2002